Oct
2026
Fiera Milano, Italy
Visit us
stand 20F72, Finished Dosage & Formulation

D&V Farma srl

Exhibitor at CPHI Milan 2026
About Us

D&V Farma is a B2B R&D company focused on science-driven innovation in ophthalmology and international partnering. We develop and license-out ophthalmic medical devices and food supplements based on innovative raw materials, solid scientific rationale, and preclinical/clinical data. We build protectable assets (patents, trademarks) and support market-ready positioning. Meet us at Vitafoods Europe 2026 for licensing and partnerships.

Read more Show less
Sales Markets
Show more Show less
Categories
more categories Show less
  • Country/Region:
    Italy
  • On CPHI since:
    2023
  • Certificates:
    1
  • Employees:
    1 - 24
Company types
Consumer Goods
Manufacturer/Innovator
OTC
Pharmaceutical company
Primary activities
Medical Devices
Nutraceuticals
Out-licensing specialist
View company profile
Contact info
Show contact info Hide contact info
Event information
CPHI Milan 2026
  • 6 Oct 2026 - 8 Oct 2026
  • Fiera Milano, Italy
  • Visit us at stand 20F72, Finished Dosage & Formulation

Products Featured at CPHI Milan 2026

  • CORDEV

    Product CORDEV

    CORDEV has been designed for corneal protection, It has a solid scientific foundation and is supported by clinical and preclinical data that confirm its effectiveness. It is patented, and the trademark is registered in the European Union and the UK. Clinical and preclinical data have been published in...
  • CROSE

    Product CROSE

    Patent-pending dietary supplement developed to support retinal function and macular health in cases of central serous chorioretinopathy, with a targeted formulation designed to sustain the physiological mechanisms involved in cortisol regulation and to protect retinal epithelial and ganglion cells.
  • DIAX-D

    Product DIAX-D

    Patent pending dietary supplements desigend for subject affected by diabetic retinopathyIt is able to:Reduce VEGF expressionInhibits vessel formationRestore retinal ability to respond to stimuli

    And It has a neuroprotective function.
  • DIVICOR

    Product DIVICOR

    DIVICOR is a product designed for the treatment of corneal alterations in diabetic patients, It is patented, and the trademark is registered in the European Union and the UK. It has a solid scientific foundation and is supported by clinical and preclinical data demonstrating its effectiveness. Clinica...
  • SIALIX

    Product SIALIX

    Patent pending dietary supplement designed for subjects affected by glaucoma.It is able to:Reduce VEGF expressionInhibits vessel formationRestore retinal ability to respond to stimuli

    And It has a neuroprotective function.